Medical innovations firm BTG reported a full year pre-tax profit,
driven by growing recurring revenues and litigation settlements
that threatened to dissolve into a long running legal dispute.
New research has suggested that that pharmacological inhibition of
a protein's role in Alzheimer's, Parkinson's and cancer research
could be key to either preventing or promoting cell death.
SAFC Supply Solutions has introduced new phosphoramidites and
ancillary reagents for oligonucleotide (oligo) synthesis, promising
consistent quality, tight specifications and reliability.
deltaDOT launches a unique capillary-based DNA sequencer that has
been specifically developed to provide a low-cost rapid throughput
DNA sequencing solution in numerous drug discovery applications.
Thermo Electron has announced the availability of further
enhancements to its Galileo LIMS, which aims to provide additional
capabilities for high throughput ADMET experiments that facilitate
lead optimisation in drug discovery.
Determined to eradicate a disease that takes the lives of more than
one million people worldwide each year, Novartis has announced it
will participate in a new public-private partnership which aims to
discover more potent drugs to...
China could be the first country to conduct human stem cell trials
and presents a significant opportunity for Western companies who
are brave enough to use this risky destination as a place to pursue
this potentially lucrative sector...
The gastrointestinal (GI) market is one of the largest in the
pharma industry and continues to attract a high level of R&D
investment, however, the market has recently entered a crucial
phase, with mounting commercial pressures...
In what it claims is the largest investment to date by any
multinational drug company in China, AstraZeneca will spend $100m
(€77.6m) on research and development in the country over the next
three years, targeting primarily the domestic...
Sigma-Aldrich introduces its signal transduction protein array for
high-throughput functional screening, which is set to play a major
role in identifying proteins that are involved in cellular
processes including proliferation, differentiation...
Microbia has presented clinical data that shows its first-in-class
drug for the treatment of constipation-predominant irritable bowel
syndrome (IBS-C) and chronic constipation (CC), demonstrated
promising pharmacodynamic effects.
A new drug discovery approach, which essentially reverses the
process of drug compound screening promises a increased efficiency
in drug discovery whilst keeping costs down to a minimum.
According to a new report, the European central nervous system
therapeutic market is set to capitalise on an ageing population, a
high level of unmet clinical need and increasing prevalence of
neurological disorders, growing to $31.31bn...
Cisbio has introduced its second IP-One assay, which can be used by
all laboratories focused on GPCR-based targets of which 45 per cent
of currently marketed drugs owe their efficacy to.
Accium BioSciences and Quintiles Transnational has established an
agreement, which intends to offer turnkey Exploratory-IND,
Microdosing and Information-Rich Phase I clinical trials services
to biopharmaceutical researchers.
Abraxis Bioscience has added a research facility to expand the
company's research and process development capabilities that use
the company's nab technology platform, which identifies new
chemical entities and exploitation...
General Electric and MDS Pharma Services announced today the
availability of a new, automated in vitro micronucleus assay that
will form part of a broad panel of drug discovery safety
assessments offered by MDS Pharma Services pharmacology...
Cambridge Antibody Technology (CAT) posted a first-half profit for
the year that was attributed to royalty payments for its Humira
rheumatoid arthritis drug.
Contract biomanufacturing firm Laureate has won a contract to
produce Seattle Genetics' humanised monoclonal antibody product
candidates for clinical trial, adding to its experience in
monoclonal antibody development.
Biophage has completed the final phase of its CRO business
restructuring in preparation to meet the expected demand in
immunotoxicity testing, in which its requirement stems from
increasing legislation that calls for stricter standards.
A new drug discovery technique, which uses mixed-mode sorbents in
process chromatography, has the potential to significantly reduce
costs and environmental burdens, especially in the protein
purification process.
US scientists have uncovered a mechanism of action that explains
how cells respond to DNA damage and other stresses that if
disrupted can cause cancer. The discovery could lead to new
diagnostic markers and cancer treatments with...
A team of drug researchers are exploring the possibility of
extracting chemical compounds from marine organisms that live in
deep-sea reefs, which have the potential to treat human diseases
such as cancer and Alzheimer's.
The World Health Organisation is calling for greater transparency
in clinical trials by announcing new registration standards for all
medical research involving humans.
A potential therapy, which specifically targets cancer cells, could
be in the offering after Neotropix received FDA approval to begin
clinical trials of a drug candidate that offers new drug treatment
hope for advanced cancers.
Software provider Pharsight, has been awarded a patent on its
graphical method for creating drug models, in a technique that
supports more intuitive PK/PD modelling and higher modelling
productivity.
Oxford University has made another trip to the High Court with the
intention of further limiting the number of animal rights protests,
which the institution claim is responsible for an increase in
criminal damage and staff intimidation.
US scientists have discovered a way to improve the effectiveness of
antisense cancer drugs that involve using gold nanoparticles, which
when combined with DNA, outperform conventional antisense agents.
Researchers, who believe they have discovered only the third
entirely new antibiotic developed in the last four decades, have
developed an antibiotic, which targets microorganisms that include
MRSA.
A novel lab technique, which involves RNA interference to silence
genes in immune cells, is set to provide biology researchers
broader access to RNA interference, especially for scientists doing
research in immunology.
Berthold Technologies used Analytica to showcase its innovative new
instruments that will open up new opportunities for users in
bioimedical and pharmaceutical research.
UK Prime Minister Tony Blair has made the unprecedented step of
pledging his personal support for animal testing, provoking an
angry reaction from anti-vivisectionists.
deCODE and Illumina have entered an agreement to develop and
commercialise DNA-based diagnostics, in which deCODE will use
Illumina's SNP genotyping platform to expand its contract
genotyping business.
Nikon launches a new three-laser entry-level confocal microscope,
which builds on the technology of its entry-level system, which
meets the growing popularity of confocal imaging in research
applications.
SAFC Biosciences has unveiled an analogue of insulin specifically
designed for the large-scale manufacturing of recombinant
biopharmaceuticals, promising security of supply and product
consistency.
A new study has suggested a new approach to drug design, which
recommends that a loose fit may be the best fit especially when
producing drugs for thyroid related conditions.
European researchers have unlocked more secrets of how the HIV and
SARS virus operates, which if exploited could be the starting point
for a host of effective antiviral drugs that combat the virus'
mechanism of action.
Agilent has launched a new line of HPLC columns, which is set to
deliver industry-leading separation performance for analytical,
high-resolution and fast LC applications, including pharmaceutical,
QA/QC, environmental and food-safety...
A research team think that they have discovered a new mechanism
that details the role of sugar in cell communication, which paves
the way for the development of drugs for cancer and rheumatism.
The High Court in the UK has granted an injunction to protect
GlaxoSmithKline (GSK) shareholders against the recent threat posed
by animal extremists, who contacted investors by mail warning them
to sell their shares in the company.
A new report suggests the increasing number of collaboration
between pharmaceutical and biotech companies is fuelled by a steep
decline in innovation levels as well as the growing threat from
generics and drug recalls.
Thermo Electron is set to become the biggest supplier of laboratory
equipment and services after it paid $10.6bn to acquire Fisher
Scientific International in a deal that extends Thermo's presence
in the life, laboratory and...
Animal rights activists have continued their campaign of
intimidation after it was revealed the GlaxoSmithkline (GSK)
shareholders were sent letters demanding they sell any shares held
within the company.
A new genetic research method has revealed interesting insights
into drug metabolism, which could lead to a better understanding
drug selection and dosing regimens in humans.
A new initiative that could see the world's major pharmaceutical
and biotechnology companies team up with a major cancer
organisation to research and develop new anti-cancer drugs has been
unveiled.
The first all-in-one SERS toolkit designed for trace level
molecular analysis has debuted at Analytica, which provides
analytical chemists with an affordable, all-in-one solution for the
development of trace level analysis applications.
CyBio presents its new liquid handling platform and pipetting
system at Analytica in Munich, which aims to meet customer needs in
drug discovery processes that require precision and accuracy when
handling fluid materials.
Scientists believe they have made a major breakthrough in a
potential cure for diabetes after animal experiments using a
combinatorial treatment approach reversed onset type 1 diabetes.